Literature DB >> 6120392

Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro.

I Juhan, P Vague, M Buonocore, J P Moulin, R Jouve, B Vialettes.   

Abstract

Erythrocyte deformability is lower than normal in uncontrolled insulin-dependent diabetics and returns towards normal after 24 h treatment with a feedback-controlled insulin infusion. Deformability of normal erythrocytes is reduced by incubation in plasma from uncontrolled insulin-dependent diabetics but is normal in plasma from insulin-dependent diabetics controlled by 24 h insulin infusion, or in plasma from uncontrolled insulin-dependent diabetics with insulin added in vitro. Therefore, insulin has a direct action on erythrocyte deformability. Platelet aggregation measured in whole blood is raised in uncontrolled insulin-dependent diabetics and returns to normal after 24 h treatment with a feedback-controlled insulin infusion. Aggregation of normal platelets rises in the presence of erythrocytes from uncontrolled insulin-dependent diabetics, but not erythrocytes from the same patients after 24 h treatment with insulin. The effect of insulin on platelet aggregation therefore seems to be at least partly mediated by erythrocytes. The enhanced platelet aggregation seen in uncontrolled insulin-dependent diabetics can be explained either by a direct effect of erythrocyte rigidity or by an increased release of nucleotides (ADP) by the erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120392     DOI: 10.1016/s0140-6736(82)92045-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

Review 1.  The clinical importance of erythrocyte deformability, a hemorrheological parameter.

Authors:  F C Mokken; M Kedaria; C P Henny; M R Hardeman; A W Gelb
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

2.  Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.

Authors:  H P Hammes; A Weiss; D Führer; H J Krämer; C Papavassilis; F Grimminger
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 3.  Erythrocyte rheology.

Authors:  J Stuart
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

4.  Modification of the glyoxalase system in human red blood cells by glucose in vitro.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

5.  Real and artefactual erythrocyte swelling in hyperglycaemia.

Authors:  H A Bock; R Flückiger; W Berger
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

6.  Decreased deformability of erythrocytes in hyperglycaemic non-inbred ob/ob mice.

Authors:  K G Engström; I B Täljedal
Journal:  Diabetologia       Date:  1986-09       Impact factor: 10.122

7.  Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type 1 (insulin-dependent) diabetic patients.

Authors:  I Juhan-Vague; D Rahmani-Jourdheuil; Z Mishal; C Roul; Y Mourayre; M F Aillaud; P Vague
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

Review 8.  Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.

Authors:  A Ceriello
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

9.  Correction by pentoxifylline of the abnormal fluorescence polarization of erythrocyte membranes from diabetic patients.

Authors:  D Rahmani-Jourdheuil; I Juhan-Vague; C Roul; Y Mourayre; Z Mishal; J le Petit; P Vague
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry.

Authors:  N H Schut; E C van Arkel; M R Hardeman; H J Bilo; R P Michels; J Vreeken
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.